BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2093360)

  • 1. [Increase of circulating levels of insulin and C-peptide: common factors in essential hypertension and overweight].
    Sechi LA; Tedde R; Melis A; Pala A; Marigliano A; Orecchioni C; Pisanu G; Bartoli E
    Ann Ital Med Int; 1990; 5(4 Pt 1):348-52. PubMed ID: 2093360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance and beta-cell hypersecretion in essential hypertension.
    Sechi LA; Tedde R; Marigliano A; Melis A; Pala A; Orecchioni C
    J Hypertens Suppl; 1990 Sep; 8(4):S87-9. PubMed ID: 2258791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives.
    Feldstein CA; Renauld A; Akopian M; Olivieri AO; Garrido D
    J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study on the mechanism of hyperinsulinemia in essential hypertension].
    Guan RJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Oct; 21(5):266-8, 314. PubMed ID: 8200304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans.
    Lyoussi B; Ragala MA; Mguil M; Chraibi A; Israili ZH
    Clin Exp Hypertens; 2005 May; 27(4):377-94. PubMed ID: 15921074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insulin and C-peptide levels in patients with idiopathic arterial hypertension].
    Kinalska I; Borejszo I; Gosiewska A; LaudaƄski T
    Pol Tyg Lek; 1992 Jul 6-13; 47(27-28):579-82. PubMed ID: 1488331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and hypertension in postmenopausal women.
    Feldstein CA; Akopian M; Renauld A; Olivieri AO; Cauterucci S; Garrido D
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S145-50. PubMed ID: 11986914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin hypersecretion: a distinctive feature between essential and secondary hypertension.
    Sechi LA; Melis A; Tedde R
    Metabolism; 1992 Nov; 41(11):1261-6. PubMed ID: 1435300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients.
    Colussi G; Catena C; Lapenna R; Nadalini E; Chiuch A; Sechi LA
    Diabetes Care; 2007 Sep; 30(9):2349-54. PubMed ID: 17575088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between blood pressure and serum insulin response in glucose intolerant subjects.
    Ansari AJ; Miah AK
    Bangladesh Med Res Counc Bull; 1995 Aug; 21(2):55-63. PubMed ID: 8815863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of fasting and post oral glucose serum insulin levels in hypertensive and obese subjects.
    Kothari K; Mathur A; Yadav S
    J Assoc Physicians India; 1998 Jun; 46(6):514-7. PubMed ID: 11273248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOMA-estimated insulin resistance is associated with hypertension in Iranian diabetic and non-diabetic subjects.
    Esteghamati A; Khalilzadeh O; Abbasi M; Nakhjavani M; Novin L; Esteghamati AR
    Clin Exp Hypertens; 2008 Jul; 30(5):297-307. PubMed ID: 18633753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stepwise increase in plasma insulin and C-peptide concentrations in obese, in obese hypertensive, and in obese hypertensive diabetic subjects.
    Donatelli M; Scarpinato A; Bucalo ML; Russo V; Iraci T; Vassallo G
    Diabetes Res; 1991 Jul; 17(3):125-9. PubMed ID: 1841027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians.
    Saad MF; Knowler WC; Pettitt DJ; Nelson RG; Mott DM; Bennett PH
    Diabetes; 1990 Nov; 39(11):1430-5. PubMed ID: 2227116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension.
    Golan E; Tal B; Dror Y; Korzets Z; Vered Y; Weiss E; Bernheim J
    Isr Med Assoc J; 2002 Jun; 4(6):426-30. PubMed ID: 12073415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.
    Bigazzi R; Bianchi S; Batini V; Guzzo D; Campese VM
    Am J Hypertens; 2006 Apr; 19(4):426-31. PubMed ID: 16580581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum insulin, insulin sensitivity, and erythrocyte sodium metabolism in normotensive and essential hypertensive subjects with and without overweight.
    Sechi LA; Melis A; Pala A; Marigliano A; Sechi G; Tedde R
    Clin Exp Hypertens A; 1991; 13(2):261-76. PubMed ID: 2065466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 20-Hydroxyeicosatetraenoic acid is not associated with circulating insulin in lean to overweight humans.
    Ward NC; Hodgson JM; Puddey IB; Beilin LJ; Croft KD
    Diabetes Res Clin Pract; 2006 Nov; 74(2):197-200. PubMed ID: 16713008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behavior of C-peptide and immunoreactive insulin in essential obesity].
    Gragnoli G; Signorini AM; Tanganelli I; Martinelli G
    Boll Soc Ital Biol Sper; 1979 Mar; 55(6):564-70. PubMed ID: 399187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.